^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    YB-200

    i
    Other names: YB-200
    Associations
    News
    Trials
    Company:
    Ymmunobio
    Drug class:
    CEACAM1 agonist, CEACAM5 agonist
    Associations
    News
    Trials